Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker

Fangjia Lu, Irene Boutselis, Richard F. Borch, Harm HogenEsch

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The strongest mechanism for adsorption of antigens to aluminum adjuvants is ligand exchange, which involves the replacement of a surface hydroxyl on the adjuvant by a terminal phosphate group of the antigen. A novel phosphonate linker was developed that allows the addition of phosphonate (C-PO3) groups to proteins under controlled and chemically mild conditions. Increasing the number of linkers per protein molecule progressively increased the adsorption strength to aluminum hydroxide adjuvant (AH) as measured by elution in serum. The effect of phosphonate conjugation on the antibody response was determined with hen egg lysozyme (HEL), a protein that has the same charge as AH at neutral pH and does not adsorb to AH. The phosphonylated form of HEL (HEL-P) adsorbed to AH, indicating that the ligand exchange interaction could overcome the electrostatic repulsion. Mice injected with HEL-P/AH had a higher antibody titer to HEL than mice injected with HEL/AH, especially at lower antigen doses, suggesting that adsorption of antigen has a dose-sparing effect. Conjugation of CRM197, an antigen that adsorbs electrostatically to AH, with phosphonate linkers did not enhance the antibody response, indicating that adsorption by either electrostatic or ligand exchange to AH is sufficient to enhance the antibody response.

Original languageEnglish (US)
Pages (from-to)4362-4367
Number of pages6
JournalVaccine
Volume31
Issue number40
DOIs
StatePublished - Sep 13 2013
Externally publishedYes

Fingerprint

phosphonates
Aluminum Hydroxide
Organophosphonates
Aluminum
aluminum hydroxide
adjuvants
aluminum
immune response
antigens
Antigens
lysozyme
hens
Adsorption
Antibody Formation
adsorption
Ligands
Static Electricity
antibodies
Proteins
eggs

Keywords

  • Adsorption
  • Aluminum adjuvant
  • Ligand exchange
  • Phosphate

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker. / Lu, Fangjia; Boutselis, Irene; Borch, Richard F.; HogenEsch, Harm.

In: Vaccine, Vol. 31, No. 40, 13.09.2013, p. 4362-4367.

Research output: Contribution to journalArticle

Lu, Fangjia ; Boutselis, Irene ; Borch, Richard F. ; HogenEsch, Harm. / Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker. In: Vaccine. 2013 ; Vol. 31, No. 40. pp. 4362-4367.
@article{ddaf8470b9d246a38083098f937d50fd,
title = "Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker",
abstract = "The strongest mechanism for adsorption of antigens to aluminum adjuvants is ligand exchange, which involves the replacement of a surface hydroxyl on the adjuvant by a terminal phosphate group of the antigen. A novel phosphonate linker was developed that allows the addition of phosphonate (C-PO3) groups to proteins under controlled and chemically mild conditions. Increasing the number of linkers per protein molecule progressively increased the adsorption strength to aluminum hydroxide adjuvant (AH) as measured by elution in serum. The effect of phosphonate conjugation on the antibody response was determined with hen egg lysozyme (HEL), a protein that has the same charge as AH at neutral pH and does not adsorb to AH. The phosphonylated form of HEL (HEL-P) adsorbed to AH, indicating that the ligand exchange interaction could overcome the electrostatic repulsion. Mice injected with HEL-P/AH had a higher antibody titer to HEL than mice injected with HEL/AH, especially at lower antigen doses, suggesting that adsorption of antigen has a dose-sparing effect. Conjugation of CRM197, an antigen that adsorbs electrostatically to AH, with phosphonate linkers did not enhance the antibody response, indicating that adsorption by either electrostatic or ligand exchange to AH is sufficient to enhance the antibody response.",
keywords = "Adsorption, Aluminum adjuvant, Ligand exchange, Phosphate",
author = "Fangjia Lu and Irene Boutselis and Borch, {Richard F.} and Harm HogenEsch",
year = "2013",
month = "9",
day = "13",
doi = "10.1016/j.vaccine.2013.07.019",
language = "English (US)",
volume = "31",
pages = "4362--4367",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "40",

}

TY - JOUR

T1 - Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker

AU - Lu, Fangjia

AU - Boutselis, Irene

AU - Borch, Richard F.

AU - HogenEsch, Harm

PY - 2013/9/13

Y1 - 2013/9/13

N2 - The strongest mechanism for adsorption of antigens to aluminum adjuvants is ligand exchange, which involves the replacement of a surface hydroxyl on the adjuvant by a terminal phosphate group of the antigen. A novel phosphonate linker was developed that allows the addition of phosphonate (C-PO3) groups to proteins under controlled and chemically mild conditions. Increasing the number of linkers per protein molecule progressively increased the adsorption strength to aluminum hydroxide adjuvant (AH) as measured by elution in serum. The effect of phosphonate conjugation on the antibody response was determined with hen egg lysozyme (HEL), a protein that has the same charge as AH at neutral pH and does not adsorb to AH. The phosphonylated form of HEL (HEL-P) adsorbed to AH, indicating that the ligand exchange interaction could overcome the electrostatic repulsion. Mice injected with HEL-P/AH had a higher antibody titer to HEL than mice injected with HEL/AH, especially at lower antigen doses, suggesting that adsorption of antigen has a dose-sparing effect. Conjugation of CRM197, an antigen that adsorbs electrostatically to AH, with phosphonate linkers did not enhance the antibody response, indicating that adsorption by either electrostatic or ligand exchange to AH is sufficient to enhance the antibody response.

AB - The strongest mechanism for adsorption of antigens to aluminum adjuvants is ligand exchange, which involves the replacement of a surface hydroxyl on the adjuvant by a terminal phosphate group of the antigen. A novel phosphonate linker was developed that allows the addition of phosphonate (C-PO3) groups to proteins under controlled and chemically mild conditions. Increasing the number of linkers per protein molecule progressively increased the adsorption strength to aluminum hydroxide adjuvant (AH) as measured by elution in serum. The effect of phosphonate conjugation on the antibody response was determined with hen egg lysozyme (HEL), a protein that has the same charge as AH at neutral pH and does not adsorb to AH. The phosphonylated form of HEL (HEL-P) adsorbed to AH, indicating that the ligand exchange interaction could overcome the electrostatic repulsion. Mice injected with HEL-P/AH had a higher antibody titer to HEL than mice injected with HEL/AH, especially at lower antigen doses, suggesting that adsorption of antigen has a dose-sparing effect. Conjugation of CRM197, an antigen that adsorbs electrostatically to AH, with phosphonate linkers did not enhance the antibody response, indicating that adsorption by either electrostatic or ligand exchange to AH is sufficient to enhance the antibody response.

KW - Adsorption

KW - Aluminum adjuvant

KW - Ligand exchange

KW - Phosphate

UR - http://www.scopus.com/inward/record.url?scp=84882872051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882872051&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2013.07.019

DO - 10.1016/j.vaccine.2013.07.019

M3 - Article

C2 - 23887038

AN - SCOPUS:84882872051

VL - 31

SP - 4362

EP - 4367

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 40

ER -